Standard & Poor's
http://www2.standardandpoors.comStandard & Poor’s, a division of McGraw-Hill (NYSE: MHP), produces financial research and analysis on stocks and bonds. It provides credit ratings on public and private corporations and is designated as a Nationally Recognized Statistical Rating Organization (NRSRO) by the SEC. The firm’s long-term credit ratings range from “AAA” to “D” and its short-term credit ratings range from “A-1” to “D”. Standard & Poor’s also publishes indexes including the S&P 500.
-
StreetInsider.com Pre-Open Movers 4/25: (AKAM) (INFN) (FIO) Higher; (XIDE) (INTU) (CTXS) Lower (more...)
-
Jefferies Lifts PT on Pharmaceuticals Stocks (ABBV) (NVS) (SNY) (PFE)
-
Market Wrap: (Most) Banks Pass Fed Muster; JPMorgan in Senate Hot Seat; Kerkorian Likes MGM
-
S&P 500 (SPY) is Going Higher Because Analyst Carter Worth Says So
-
Top 10 News Items 7/2-7/6: Private Sector Showed Slowest Pace of Job Growth in 10 Months; Central Banks React; Mergers Get Serious on Monday
-
Market Wrap: US Manufacturing Hits the Skids; Apple Settles 'iPad' Suit; Merger Monday!
-
S&P Biotech EFT (XBI) Pops on Amylin (AMLN) Buyout News
-
Market Wrap: Greece's New FinMin; News Corp May Divide, Conquer; Drop in Home Prices Slow; the Zynga Show
-
Top 10 News Items 1/9-1/13: S&P Downgrades Slew of Euro Nations; JPMorgan Q4 Sales Disappoint; Bristol-Myer's Bid for Inhibitex Heats Up Drug Sector
-
Solar Rules, Retail Drools Early in 2012 (TAN) (XRT)
-
Market Wrap: Bristol-Myers/Inhibitex Get Together; Netflix Across the Pond; Credit Spending Booms
-
Barclays 2012 Top Picks: Becoming Somewhat More Optimistic - Signs of Progress, Growth and Soft Landings
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
-
Daily State of the Markets 02/07: Irrelevant?
-
Daily State of the Markets 10/04: Pressing Pause (Again)
-
Citi on U.S. Major Pharmaceuticals: 2Q10 Outperformance Expected
-
Notable ETF Movers of the Day 06/11: XLV, GLD, UNG Up; KBE, USO, XHB Down (PFE, BMY)
-
Citi Issues Q1 Preview on U.S. Major Pharmaceuticals; Merck (MRK) Remains 'Top Pick'
-
Bristol-Myers Squibb (BMY) Completes Exchange Offer and Split-Off of Mead Johnson Nutrition (MJN)
-
S&P Announces Changes to US Indices: MJN, V, ROST, CLF, SAI In S&P 500, MBI, CIEN, DYN, KBH, CVG Out
-
Notable ETF Movers: PGM, XLV, SMH Up; UNG, KRE, FXI, AGQ, XME Down
-
David Moenning�s Daily State of the Markets: 8/28
-
Trading Radar for 4/28: Bristol-Myers Squibb (BMY), Pfizer (PFE), BP (BP), Sun Micro (JAVA), Deutsche Bank (DB), E*TRADE (ETFC), Level 3 (LVLT) Report; Consumer Confidence Due
-
David Moenning's Daily State of the Markets: 1/27
-
Trading Radar for 1/27: Yahoo! (YHOO), DuPont (DD), US Steel (X), Verizon (VZ), Bristol Myers (BMY) Report; Consumer Confidence Due
-
Unusual 11 Mid-Day Movers 9/10: ACBA, AVAV, STLD, RBN Higher; ENCO, DTG, GFIG, WM Lower
-
ETF Movers: Biotech ETFs On the Moves Following ImClone Offer
